How to buy Align Technology (ALGN) shares in Australia
Learn how to easily invest in Align Technology shares.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Align Technology Inc (ALGN) is a leading medical devices business with stocks listed in the US. It opened the day at US$672.56 after a previous close of US$673.59. During the day the price has varied from a low of USD660.585 to a high of USD683.83. The latest price was USD668.12 (25 minute delay). Align Technology is listed on the NASDAQ. All prices are listed in US Dollars.
How to buy shares in Align Technology
- Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
- Search for Align Technology. Find the share by name or ticker symbol: ALGN. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Align Technology reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At last close price of US$673.59, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of Align Technology, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Align Technology. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
- Align Technology key stats
- Compare share trading platforms
- Is Align Technology stock a buy or sell?
- Align Technology performance over time
- Are Align Technology shares over-valued?
- Align Technology's financials
- How volatile are Align Technology shares?
- Does Align Technology pay a dividend?
- Other common questions
Align Technology stock price (NASDAQ:ALGN)Use our graph to track the performance of ALGN stocks over time.
Align Technology shares at a glance
|52-week range||US$494.45 - US$737.45|
|50-day moving average||US$639.5228|
|200-day moving average||US$635.1644|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||US$9.278|
Where to buy Align Technology stock
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy Align Technology stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Align Technology price performance over time
|1 month (2021-12-16)||12.28%|
|3 months (2021-10-19)||12.43%|
|6 months (2021-07-19)||12.18%|
|1 year (2021-01-19)||19.86%|
|2 years (2020-01-17)||138.02%|
|3 years (2019-01-18)||203.57%|
|5 years (2017-01-19)||637.85%|
Stocks similar to Align Technology
Is Align Technology under- or over-valued?
Valuing Align Technology stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Align Technology's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Align Technology's P/E ratio
Align Technology's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 57x. In other words, Align Technology shares trade at around 57x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Align Technology's PEG ratio
Align Technology's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.7789. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Align Technology's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Align Technology's EBITDA
Align Technology's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$1.1 billion (£0.0 million).
The EBITDA is a measure of a Align Technology's overall financial performance and is widely used to measure a its profitability.
Align Technology financials
|Revenue TTM||US$3.8 billion|
|Operating margin TTM||25.79%|
|Gross profit TTM||US$1.8 billion|
|Return on assets TTM||12.03%|
|Return on equity TTM||22.6%|
|Market capitalisation||US$41.4 billion|
TTM: trailing 12 months
Align Technology share dividends
We're not expecting Align Technology to pay a dividend over the next 12 months.
Align Technology share price volatility
Over the last 12 months, Align Technology's shares have ranged in value from as little as US$494.45 up to US$737.45. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Align Technology's is 1.5717. This would suggest that Align Technology's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Align Technology overview
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switze
Align Technology in the news
Tuesday Sector Laggards: Services, Healthcare
Noteworthy Tuesday Option Activity: ALGN, AWK, HLT
Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media
Frequently asked questions
More guides on Finder
RAT scams: How to avoid getting conned with rapid antigen tests
Don't fall for the scam artists when you're trying to protect your health - here's what to check.
How to do a COVID-19 test at home for international travel
Here's where you can book COVID-19 at-home tests approved for travel and how they work.
Where to shop every product in Kiernan Shipka’s beauty routine
We've rounded up everything you need to nail the 'date-worthy' makeup look, including some affordable dupes.
American Express Corporate Gold Card
Designed for big companies, this Amex charge card offers a mix of management tools and perks – including a 100,000 bonus Membership Rewards offer.
Rapid antigen tests: When will RAT stock be available? [UPDATED]
Rapid antigen tests are proving extremely hard to find, but there are options if you can be patient trying to find a RAT.
Beauty Product of the Week: Milk Makeup Hydro Grip Primer
We tried the viral Milk Makeup Hydro Grip Primer and spoiler alert, it's the bee's knees.
Where to watch Hotel Transylvania 4 online for free in Australia
Drac and the Pack are back, like you’ve never seen them before.
Dyson V12 Detect Slim review: Baby love, my baby love
A delightful compact vacuum with an unjustifiable price.
Stan Event: Streaming platform joins pay-per-view ranks
A new player enters the Australian sports broadcast market.
Amazon Echo Buds (2nd Gen) review: Fine if you’re already trapped by Bezos
The Amazon Echo Buds 2 are a solid addition to your earholes if you’re already integrated in the Alexa ecosystem. But if you’re not, its hard to find anything here that really stands out.
Ask an Expert